Sort
30,917 grants matching “tumor microenvironment”
Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2
$400,081E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2023 · CA
Macrophage polarization in glioma microenvironment
$400,079Yi Fan · University Of Pennsylvania · R01 · FY2018 · NS
INTERCELLULAR COMMUNICATION AND THE RADIATION-INDUCED BYSTANDER EFFECT
$400,066Edouard I Azzam · Columbia University Health Sciences · P01 · FY2013 · CA
Mechanisms of Carcinogenesis in Biliary Epithelia
$400,055Gregory J. Gores · Mayo Clinic Rochester · R01 · FY2015 · DK
CAREER: Stochastic Models of Cancer Evolution
$400,054Jasmine Y Foo · University Of Minnesota-Twin Cities · · FY2014 · MPS
Targeting metastatic tumors with engineered cellular therapies
$400,053Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · CA
A Novel Symbiotic Approach For Targeted Ovarian Cancer Therapy
$400,048Jogender Tushir-Singh · University Of Virginia · R01 · FY2019 · CA
Computational methods for in situ spatial transcriptomics
$400,034Zhicheng Ji · Duke University · R35 · FY2025 · GM
Leukocyte Biomarkers for Predicting Human Breast Cancer Outcomes
$400,001Lisa M Coussens · University Of California, San Francisco · U54 · FY2011 · CA
Nanovectors for Characterization and Destruction of Breast Tumor Vasculature
$400,000Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · R01 · FY2007 · CA
Notch function in postnatal intestinal and mesenteric lymphatics
$400,000Carrie J. Shawber · Columbia University Health Sciences · R01 · FY2021 · DK
ISS: Leveraging Microgravity to Study Immunomechanics in Cancer-Myeloid Organoids
$400,000Meenal Datta · University Of Notre Dame · · FY2024 · ENG
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
$400,000Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · AI
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
$400,000Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · AI
Optimized targeted radiotherapy of pancreatic cancer
$400,000Pinku Mukherjee · Oncotab, Inc · R41 · FY2025 · CA
A novel and effective immunotherapeutic approach for tumors with a low mutational load and few tumor-infiltrating lymphocytes, such as ovarian cancer
$400,000Jennifer June Sessions · Cynvec, Llc · R44 · FY2020 · CA
Regulation and function of nonlymphoid organ CD103 dendritic cells
$400,000Stephanie S Watowich · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · AI
Phase I/II Randomized Tiral of Adoptive Lymphocyte Transfer in Ovarian Cancer
$400,000George Coukos · University Of Pennsylvania · R01 · FY2012 · FD
Phase I/II Randomized Tiral of Adoptive Lymphocyte Transfer in Ovarian Cancer
$400,000George Coukos · University Of Pennsylvania · R01 · FY2008 · FD
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
$400,000Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · AI
Evaluation of lead FANA oligos targeting FOXP3, with and without anti-PD-1 mAb, as an approach for cancer immunotherapy
$400,000Veenu Aishwarya · Aum Lifetech, Inc. · R43 · FY2022 · CA
Targeting STAT3 with Novel Thiomorpholino Antisense Oligonucleotides for Cancer Therapy
$400,000Xuedong Liu · Vesicle Therapeutics Inc. · R41 · FY2025 · CA
Targeting cadherin-11 in pancreatic cancer
$400,000Sivanesan Dakshanamurthy · Diviner Therapeutics, Llc · R41 · FY2022 · CA
Engineering next generation supercharged CAR T-cells against solid tumors
$400,000Premal Patel · Cellinfinity Bio, Inc. · R43 · FY2023 · CA
Molecular Mechanisms Regulating TLR Signaling and Macrophage Activation.
$400,000Shao-Cong Sun · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · AI